[PAR] YoY Quarter Result on 30-Jun-2018 [#Q4]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
29-Jun-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q4]
Profit Trend
QoQ- 26.76%
YoY- -79.62%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 21 -826 2,956 2,660 1,766 1,244 0 -
PBT -13,567 -7,195 -11,227 -2,617 -1,457 -1,502 -960 55.42%
Tax 0 -826 2,956 0 0 0 2 -
NP -13,567 -7,195 -11,227 -2,617 -1,457 -1,502 -960 55.42%
Tax Rate - - - - - - - -
Total Cost 13,587 6,369 14,183 5,277 3,223 2,746 960 55.46%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -66,017.95 871.10 -379.84 -98.38 -82.52 -120.68 0.00 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.06 -0.03 -0.08 -0.02 -0.01 -0.02 -0.02 20.07%
EPS Diluted -0.06 -0.03 -0.08 -0.02 -0.01 -0.02 -0.02 20.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.